LEADER 01169nam0-22003731i-450- 001 990002405730203316 005 20071106161532.0 010 $a84-9740-004-6 035 $a000240573 035 $aUSA01000240573 035 $a(ALEPH)000240573USA01 035 $a000240573 100 $a20050308h2002----km-y1itay50------ba 101 0 $aspa 102 $aES 105 $aa|||z|||001yy 200 1 $a<> sombra del Caudillo$fMartín Luis Guzmán$gedición, introducción y notas de Antonio Lorente Medina 210 $aMadrid$cCastalia$dcopyr. 2002 215 $a333 p., [4] c. di tav.$cill.$d18 cm 225 2 $aClásicos Castalia$v266 410 0$12001$aClásicos Castalia 676 $a863.6 700 1$aGUZMÁN,$bMartín Luis$0175826 702 1$aLORENTE MEDINA,$bAntonio 801 2$aIT$bsalbc$gISBD 912 $a990002405730203316 951 $aVI.5.A. 33(II sp A 487)$b187021 L.M.$cVI.5.$d00118850 959 $aBK 969 $aUMA 979 $aPAOLA$b90$c20050308$lUSA01$h1359 979 $aANNAMARIA$b90$c20060927$lUSA01$h1314 979 $aANNAMARIA$b90$c20071106$lUSA01$h1615 996 $aSombra del caudillo$9541354 997 $aUNISA LEADER 00962nam0 22002651i 450 001 UON00263058 005 20231205103721.93 100 $a20050419d1931 |0itac50 ba 101 $afin 102 $aFI 105 $a|||| ||||| 200 1 $aAatamin puvussa... ja vähän Eevankin$eKevyt romaani$fAgapetus 205 $a4. p 210 $aHelsingissä$cKustannusosakeyhtiö Otava$d1931 215 $a221 p.$d19 cm. 620 $aFI$dHelsinki$3UONL000062 676 $a894.541$cLetteratura Finlandese$v21 700 0$aAGAPETUS$3UONV153168$0689969 712 $aOtava$3UONV270694$4650 801 $aIT$bSOL$c20240220$gRICA 899 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$2UONSI 912 $aUON00263058 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI FIU A 0233 $eSI MR 11415 5 0233 996 $aAatamin puvussa... ja vähän Eevankin$91236620 997 $aUNIOR LEADER 02172oas 2200769 a 450 001 9910898161503321 005 20251105213014.0 035 $a(DE-599)ZDB2503429-7 035 $a(OCoLC)233823514 035 $a(CONSER) 2008213691 035 $a(CKB)1000000000429008 035 $a(EXLCZ)991000000000429008 100 $a20080714a20099999 uy a 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aMolecular and cellular pharmacology 210 $aEllicott City, MD $cLumitext Pub 300 $aRefereed/Peer-reviewed 311 08$a1938-1247 531 0 $aMol. cell. pharmacol. 531 10$aMol Cell Pharmacol 606 $aMolecular pharmacology$vPeriodicals 606 $aCells$xEffect of drugs on$vPeriodicals 606 $aPharmacological Phenomena 606 $aCells$xdrug effects 606 $aBiochemical Phenomena 606 $aPharmacologie mole?culaire$vPe?riodiques 606 $aCellules$xEffets des me?dicaments sur$vPe?riodiques 606 $aCells$xEffect of drugs on$2fast$3(OCoLC)fst00850258 606 $aMolecular pharmacology$2fast$3(OCoLC)fst01024822 608 $aPeriodical. 608 $aPeriodicals.$2fast 615 0$aMolecular pharmacology 615 0$aCells$xEffect of drugs on 615 12$aPharmacological Phenomena. 615 22$aCells$xdrug effects. 615 22$aBiochemical Phenomena. 615 6$aPharmacologie mole?culaire 615 6$aCellules$xEffets des me?dicaments sur 615 7$aCells$xEffect of drugs on. 615 7$aMolecular pharmacology. 676 $a615.7 801 0$bNSD 801 1$bNSD 801 2$bNSD 801 2$bDLC 801 2$bNLM 801 2$bHEBIS 801 2$bOCLCQ 801 2$bOCLCF 801 2$bOCLCQ 801 2$bCUS 801 2$bOCLCQ 801 2$bVT2 801 2$bOCLCO 801 2$bOCLCA 801 2$bOCLCQ 801 2$bOCLCL 801 2$bLND 801 2$bOCLCQ 906 $aJOURNAL 912 $a9910898161503321 996 $aMolecular and cellular pharmacology$94213761 997 $aUNINA